Fundraising Fox

Arrogene

Los Angeles, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

JS
JEFFREY SPERBERExecutive
MV
MAURIZIO VECCHIONEExecutive
JL
JULIA LJUBIMOVANamed on SEC filing

Board

RS
ROBERT STUCKELMANBoard director
RS
RANDOLPHE SWENSONBoard director

Investors · 1

Multiverse InvestmentreportedSan Diego

Reported raises · per SEC filings

Form D private placements

$6.1M disclosed across 7 of 8 rounds · 2012–2019

▶$10KraisedOct 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Larry A. CoutureExecutive Officer, Director
  • James HoschDirector
  • Jack KavanaughExecutive Officer, Director
  • Robert SnukalDirector
  • Julia LjubimovaExecutive Officer, Director
Offering amount
$990K
Amount sold
$10K
Minimum investment
$10K
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$524.9KraisedMay 2018 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James HoschDirector
  • Robert SnukalDirector
  • Jack KavanaughExecutive Officer, Director
  • Larry A. CoutureExecutive Officer, Director
  • Julia LjubimovaExecutive Officer, Director
Offering amount
$1M
Amount sold
$524.9K
Sales commissions
$13.5K
Placement agents
GVC Capital LLC, Westpark Capital Inc.
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedMar 2018 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JULIA LJUBIMOVAExecutive Officer, Director
  • Robert SnukalDirector
  • Jack KavanaughExecutive Officer, Director
  • James HoschDirector
  • Larry A. CoutureExecutive Officer, Director
Offering amount
$2.8M
Amount sold
$2.7M
Sales commissions
$36.2K
Placement agents
GVC Capital LLC, Westpark Capital Inc.
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedMar 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MAURIZIO VECCHIONEExecutive Officer, Director
  • Jack KavanaughExecutive Officer, Director
  • JULIA LJUBIMOVAExecutive Officer, Director
  • ROBERT STUCKELMANDirector
  • Randolphe SwensonDirector
  • JEFFREY SPERBERExecutive Officer
Offering amount
$5M
Amount sold
$750K
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY SPERBERExecutive Officer
  • JULIA LJUBIMOVAExecutive Officer, Director
  • MAURIZIO VECCHIONEExecutive Officer, Director
  • ROBERT STUCKELMANDirector
  • RANDOLPHE SWENSONDirector
Offering amount
$1M
Amount sold
$250K
Minimum investment
$25K
Sales commissions
$32.5K
Placement agents
GVC CAPITAL, WESTPARK CAPITAL
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$700KraisedMay 2014 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROBERT STUCKELMANDirector
  • MAURIZIO VECCHIONEExecutive Officer, Director
  • JULIA LJUBIMOVAExecutive Officer, Director
  • JEFFREY SPERBERExecutive Officer
Offering amount
$700K
Amount sold
$700K
Minimum investment
$25K
Sales commissions
$91K
Placement agents
WESTPARK CAPITAL
First sale
Feb 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedFeb 2012 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROBERT STUCKELMANDirector
  • JULIA LJUBIMOVAExecutive Officer, Director
  • MAURIZIO VECCHIONEExecutive Officer, Director
  • JEFFREY SPERBERExecutive Officer
Offering amount
$4.8M
Amount sold
$1.1M
Minimum investment
$5K
Sales commissions
$111.2K
Placement agents
WESTPARK CAPITAL
First sale
Jan 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2012 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY SPERBERExecutive Officer
  • JULIA LJUBIMOVAExecutive Officer, Director
  • MAURIZIO VECCHIONEExecutive Officer, Director
  • ROBERT STUCKELMANDirector
First sale
Jan 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Full article: Industry Update: the Latest Developments in Therapeutic Deliverytandfonline.com

Frequently asked questions

Who are Arrogene's investors?
Arrogene's investors include Multiverse Investment.
How much funding has Arrogene raised?
Arrogene has disclosed $6.1M raised across 7 of its 8 known rounds.
Where is Arrogene headquartered?
Arrogene is headquartered in Los Angeles, US.